Sign Out
Posology: The recommended dose of SIDAPVIA is one dapagliflozin 10 mg/sitagliptin 100 mg tablet taken orally once daily at any time of the day, with or without food.
The tablet is to be swallowed whole.
Special Populations: Renal impairment: SIDAPVIA should not be used in patients with an estimated glomerular filtration rate (eGFR) <45 mL/min/1.73 m2 (see Pharmacology: Pharmacokinetics under Actions). Renal function should be evaluated prior to initiation of SIDAPVIA and periodically thereafter.
Hepatic impairment: SIDAPVIA should not be used in patients with severe hepatic impairment (see Pharmacology: Pharmacokinetics under Actions).
Paediatric and adolescent patients: Safety and effectiveness of SIDAPVIA in paediatric and adolescent patients have not been established.
Elderly patients: Older patients are more likely to have decreased renal function. The renal function recommendations provided for all patients also apply to elderly patients (see Precautions).
